Skip Navigation

British National Formulary (BNF84)


Published jointly by BMJ Publishing and Royal Pharmaceutical Society


The British National Formulary (BNF) is the first choice for concise medicines information. Trusted by healthcare professionals across the world to support confident decision-making at the point of care.

The new edition (BNF 84) provides up-to-date guidance on prescribing, dispensing, and administering medicines, plus legal and professional guidelines.

Extensive content updates in the BNF 84 edition include:

New monographs for:

  • Aspaveli® [pegcetacoplan] for paroxysmal nocturnal haemoglobinuria
  • Givlaari® [givosiran] for acute hepatic porphyria
  • Jemperli® [dostarlimab] for endometrial cancer
  • Paxlovid® [nirmatrelvir with ritonavir] for COVID-19
  • Shingrix® [herpes-zoster vaccine (recombinant, adjuvanted)] for immunisation against herpes zoster (shingles)
  • Vazkepa® [icosapent ethyl] as an adjunct to statin in prevention of cardiovascular events in hyperlipidaemia
  • Vumerity® [diroximel fumarate] for multiple sclerosis
  • Xevudy® [sotrovimab] for COVID-19
  • Xofluza® [baloxavir marboxil] for post-exposure prophylaxis or treatment of influenza

MHRA advice on:

  • Amiodarone hydrochloride (Cordarone X®): reminder of risks of treatment and need for patient monitoring and supervision
  • Brolucizumab (Beovu®): updated recommendations to minimise the known risk of intraocular inflammation, including retinal vasculitis and/or retinal vascular occlusion
  • Chloroquine: increased risk of cardiovascular events when used with macrolide antibiotics; reminder of psychiatric reactions
  • Cladribine (Mavenclad®): new advice to minimise risk of serious liver injury
  • COVID-19 antivirals: reporting to the UK COVID-19 Antivirals Pregnancy Registry
  • Haloperidol (Haldol®): reminder of risks when used in elderly patients for the acute treatment of delirium
  • Hydroxychloroquine sulfate: increased risk of cardiovascular events when used with macrolide antibiotics; reminder of psychiatric reactions
  • Ivacaftor, tezacaftor, elexacaftor (Kaftrio®▼) in combination with ivacaftor (Kalydeco®): risk of serious liver injury; updated advice on liver function testing
  • Metformin hydrochloride: study shows no safety concerns in pregnancy
  • Paclitaxel formulations (conventional and nab-paclitaxel): caution required due to potential for medication error
  • Pregabalin (Lyrica®): findings of safety study on risks during pregnancy
  • Venetoclax (Venclyxto®): updated recommendations on tumour lysis syndrome

Other significant changes include updated guidance on:

  • Antiplatelet drugs for transcatheter aortic valve implantation
  • Buprenorphine transdermal patch strengths and prescribing considerations
  • Maximum daily doses added for colecalciferol and ergocalciferol in the treatment of vitamin D deficiency
  • COVID-19 updated guidance in-line with UK Health Security Agency recommendations
  • Management of acute otitis media
  • New requirement to register patients onto Esketamine (Spravato®) Register and Alert system
  • Management of glaucoma and ocular hypertension
  • Immunisation schedule updated guidance in-line with Public Health England/UK Health Security Agency recommendations, including human papillomavirus, influenza, and varicella-zoster vaccines
  • Individual monographs created for herpes-zoster vaccine (recombinant, adjuvanted), herpes-zoster vaccine, live, and varicella-zoster vaccine
  • Miconazole oral gel no longer licensed for treatment of intestinal candidiasis
  • Obstetrics: induction of labour
  • Phosphate imbalance
  • Potassium permanganate: inadvertent oral administration of potassium permanganate [National Patient Safety Alert advice]
  • Sex hormones: use of progestogens for the prevention of miscarriage
  • Smoking cessation

BNF 84 is an essential publication, it provides you with:

Up-to-date information on prescribing, dispensing, and administering medicines
Authoritative, independent guidance on best practice enabling you to select safe and effective medicines
Information you know you can trust for quality, reliability, and independence
Everything you need at your fingertips, all in one book

British National Formulary (BNF84)

New product

£65.95


RPS MEMBER PRICE £32.95

IN STOCK

  • ISBN 9780857114327
  • Published Sep 2022
  • Paperback
    210x148mm (1824pp)

Other titles to consider...

British National Formulary Joint Formulary Committee
 

British National Formulary

Joint Formulary Committee

Now available as a 1 year print subscription, ensuring you have the latest medicines information...

£95.95

RPS Member Price £47.98
Handbook of Drug Administration via Enteral Feeding Tubes White, Rebecca; Bradnam, Vicky
 

Handbook of Drug Administration via Enteral Feeding Tubes

White, Rebecca; Bradnam, Vicky
Third edition

All you need to know about prescribing or administering drugs via enteral feeding tubes. Over...

£56.00

RPS Member Price £42.00
Hospital Pre-registration Pharmacist Training Safdar, Aamer; Ip, Shirley
 

Hospital Pre-registration Pharmacist Training

Safdar, Aamer; Ip, Shirley
First edition

A practical explanation for undergraduates and pre-registration trainees. Shows what to expect from a hospital...

£25.00

RPS Member Price £18.75

Twitter News@PharmPress

Twitter LinkedIn

Keep in touch

Follow us on LinkedIn and Twitter for the latest updates at Pharmaceutical Press